Tapewire

Nasdaq · USD

BIIB

BIOGEN INC.

Export transactions ↓
Tapewire entity
1675
SEC CIK
0000875045
Parsed reports
468

Last 12 months

Inside the activity.

1 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202612
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 02, 2026 Filed Oct 5, 2026 21:00 UTC
Godbout SeanChief Accounting Officer
Exercise / conversionRestricted Stock Unit · Derivative 27 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000084 · form4.xml · derivative · entry 4

Godbout Sean · CIK 0002057736 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 27 shares

Expires 2026-10-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of October 2, 2023.

Read SEC document
October 02, 2026 Filed Oct 5, 2026 21:00 UTC
Godbout SeanChief Accounting Officer
Tax withholdingCommon Stock 8 $219.88 $1,759.04
Disclosure

SEC source: 0000875045-26-000084 · form4.xml · nonDerivative · entry 2

Godbout Sean · CIK 0002057736 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,458.9845

Read SEC document
October 02, 2026 Filed Oct 5, 2026 21:00 UTC
Godbout SeanChief Accounting Officer
Exercise / conversionCommon Stock 27 $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000084 · form4.xml · nonDerivative · entry 1

Godbout Sean · CIK 0002057736 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,466.9845

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 98.3178 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2026, 6/30/2026, and 9/30/2026.

Read SEC document
October 01, 2026 Filed Oct 5, 2026 21:00 UTC
Godbout SeanChief Accounting Officer
GrantRestricted Stock Unit · Derivative 985 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000084 · form4.xml · derivative · entry 3

Godbout Sean · CIK 0002057736 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 985

Underlying: Common Stock · 985 shares

Expires 2029-10-01

F2 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of October 1, 2026.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:14 UTC
Parini MichaelChief Legal Officer
GrantRestricted Stock Unit · Derivative 7,405 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000082 · form4.xml · derivative · entry 1

Parini Michael · CIK 0001661567 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,405

Underlying: Common Stock · 7,405 shares

Expires 2029-09-01

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of September 1, 2026.

Read SEC document
August 04, 2026 Filed Aug 5, 2026 20:03 UTC
Minor LloydDirector
SaleCommon Stock 593 $200.96 $119,169.28
Disclosure

SEC source: 0000875045-26-000076 · form4.xml · nonDerivative · entry 2

Minor Lloyd · CIK 0002038687 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,689

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:03 UTC
Minor LloydDirector
SaleCommon Stock 593 $203.34 $120,580.62
Disclosure

SEC source: 0000875045-26-000076 · form4.xml · nonDerivative · entry 1

Minor Lloyd · CIK 0002038687 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,282

Read SEC document
June 09, 2026 Filed Jun 11, 2026 21:50 UTC GrantCommon Stock 1,505 $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000065 · form4.xml · nonDerivative · entry 1

HAWKINS WILLIAM A · CIK 0001106508 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,365

F1 · shares: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 21:47 UTC GrantCommon Stock 1,505 $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000064 · form4.xml · nonDerivative · entry 1

SHERWIN STEPHEN A · CIK 0001079462 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,193

F1 · shares: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 21:46 UTC GrantCommon Stock 1,505 $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000063 · form4.xml · nonDerivative · entry 1

Rowinsky Eric K · CIK 0001318886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,844

F1 · shares: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 21:44 UTC GrantCommon Stock 1,505 $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000062 · form4.xml · nonDerivative · entry 1

Mantas Jesus B · CIK 0001777331 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,263

F1 · shares: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 21:34 UTC
LANGER SUSANDirector
GrantCommon Stock 1,505 $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000060 · form4.xml · nonDerivative · entry 1

LANGER SUSAN · CIK 0001982640 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,634.1

F1 · shares: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 21:32 UTC GrantCommon Stock 1,505 $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000059 · form4.xml · nonDerivative · entry 1

Patolawala Monish D · CIK 0001815253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,215

F1 · shares: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 21:21 UTC Exercise / conversionRestricted Stock Unit · Derivative 2,370 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000055 · form4.xml · derivative · entry 3

Pangalos Menelas N · CIK 0002001873 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,370 shares

Expires 2026-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 17, 2025.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 21:21 UTC GrantCommon Stock 1,505 $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000055 · form4.xml · nonDerivative · entry 2

Pangalos Menelas N · CIK 0002001873 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,875

F1 · shares: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 21:21 UTC Exercise / conversionCommon Stock 2,370 $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000055 · form4.xml · nonDerivative · entry 1

Pangalos Menelas N · CIK 0002001873 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,370

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 21:17 UTC
Minor LloydDirector
GrantCommon Stock 1,505 $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000054 · form4.xml · nonDerivative · entry 1

Minor Lloyd · CIK 0002038687 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,875

F1 · shares: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 21:09 UTC GrantCommon Stock 2,005 $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000052 · form4.xml · nonDerivative · entry 1

Freire Maria C · CIK 0001547999 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,820

F1 · shares: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026.

Read SEC document
May 01, 2026 Filed May 5, 2026 20:11 UTC
Keeney AdamHead of Corporate Development
Exercise / conversionRestricted Stock Unit · Derivative 939 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000046 · form4.xml · derivative · entry 3

Keeney Adam · CIK 0001973607 · Head of Corporate Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 939 shares

Expires 2026-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of May 1, 2023.

Read SEC document
May 01, 2026 Filed May 5, 2026 20:11 UTC
Keeney AdamHead of Corporate Development
Tax withholdingCommon Stock 455 $187.06 $85,112.30
Disclosure

SEC source: 0000875045-26-000046 · form4.xml · nonDerivative · entry 2

Keeney Adam · CIK 0001973607 · Head of Corporate Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,365

Read SEC document
May 01, 2026 Filed May 5, 2026 20:11 UTC
Keeney AdamHead of Corporate Development
Exercise / conversionCommon Stock 939 $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000046 · form4.xml · nonDerivative · entry 1

Keeney Adam · CIK 0001973607 · Head of Corporate Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,820

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:05 UTC
Godbout SeanChief Accounting Officer
Exercise / conversionRestricted Stock Unit · Derivative 181 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000036 · form4.xml · derivative · entry 3

Godbout Sean · CIK 0002057736 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 364

Underlying: Common Stock · 181 shares

Expires 2028-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of April 1, 2025.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:05 UTC
Godbout SeanChief Accounting Officer
Tax withholdingCommon Stock 54 $183.78 $9,924.12
Disclosure

SEC source: 0000875045-26-000036 · form4.xml · nonDerivative · entry 2

Godbout Sean · CIK 0002057736 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,341.6667

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:05 UTC
Godbout SeanChief Accounting Officer
Exercise / conversionCommon Stock 181 $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000036 · form4.xml · nonDerivative · entry 1

Godbout Sean · CIK 0002057736 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,395.6667

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 13, 2026 Filed Feb 18, 2026 01:18 UTC
Viehbacher ChristopherDirector · President and CEO
GrantRestricted Stock Unit · Derivative 38,015 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000035 · form4.xml · derivative · entry 1

Viehbacher Christopher · CIK 0001774478 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,015

Underlying: Common Stock · 38,015 shares

Expires 2029-02-13

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.

Read SEC document
February 13, 2026 Filed Feb 18, 2026 01:17 UTC
Singhal PriyaHead of Development
GrantRestricted Stock Unit · Derivative 10,560 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000034 · form4.xml · derivative · entry 1

Singhal Priya · CIK 0001769608 · Head of Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,560

Underlying: Common Stock · 10,560 shares

Expires 2029-02-13

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.

Read SEC document
February 13, 2026 Filed Feb 18, 2026 01:16 UTC
Murphy NicoleHead of Pharm Ops and Tech
GrantRestricted Stock Unit · Derivative 10,560 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000033 · form4.xml · derivative · entry 2

Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,560

Underlying: Common Stock · 10,560 shares

Expires 2029-02-13

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.

Read SEC document
February 13, 2026 Filed Feb 18, 2026 01:14 UTC
Kramer RobinChief Financial Officer
GrantRestricted Stock Unit · Derivative 8,450 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000032 · form4.xml · derivative · entry 1

Kramer Robin · CIK 0001609222 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,450

Underlying: Common Stock · 8,450 shares

Expires 2029-02-13

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.

Read SEC document
February 13, 2026 Filed Feb 18, 2026 01:12 UTC
Keeney AdamHead of Corporate Development
GrantRestricted Stock Unit · Derivative 8,025 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000031 · form4.xml · derivative · entry 1

Keeney Adam · CIK 0001973607 · Head of Corporate Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,025

Underlying: Common Stock · 8,025 shares

Expires 2029-02-13

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.

Read SEC document
February 13, 2026 Filed Feb 18, 2026 01:11 UTC
Izzar RachidHead of Global Product Strat.
GrantRestricted Stock Unit · Derivative 7,390 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000030 · form4.xml · derivative · entry 1

Izzar Rachid · CIK 0001875506 · Head of Global Product Strat.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,390

Underlying: Common Stock · 7,390 shares

Expires 2029-02-13

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.

Read SEC document
February 13, 2026 Filed Feb 18, 2026 01:10 UTC
Grogan JaneHead of Research
GrantRestricted Stock Unit · Derivative 8,450 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000029 · form4.xml · derivative · entry 1

Grogan Jane · CIK 0001995547 · Head of Research

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,450

Underlying: Common Stock · 8,450 shares

Expires 2029-02-13

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.

Read SEC document
February 13, 2026 Filed Feb 18, 2026 01:09 UTC
Gregory GingerEVP, Human Resources
GrantRestricted Stock Unit · Derivative 8,025 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000028 · form4.xml · derivative · entry 1

Gregory Ginger · CIK 0001545716 · EVP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,025

Underlying: Common Stock · 8,025 shares

Expires 2029-02-13

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.

Read SEC document
February 13, 2026 Filed Feb 18, 2026 01:07 UTC
Godbout SeanChief Accounting Officer
GrantRestricted Stock Unit · Derivative 1,800 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000027 · form4.xml · derivative · entry 1

Godbout Sean · CIK 0002057736 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,800

Underlying: Common Stock · 1,800 shares

Expires 2029-02-13

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.

Read SEC document
February 13, 2026 Filed Feb 18, 2026 01:05 UTC
ALEXANDER SUSAN HEVP Chief Legal Officer
GrantRestricted Stock Unit · Derivative 8,450 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000026 · form4.xml · derivative · entry 1

ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,450

Underlying: Common Stock · 8,450 shares

Expires 2029-02-13

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.

Read SEC document
February 12, 2026 Filed Feb 18, 2026 01:16 UTC
Murphy NicoleHead of Pharm Ops and Tech
PurchaseCommon Stock 3 $195.04 $585.11
Disclosure

SEC source: 0000875045-26-000033 · form4.xml · nonDerivative · entry 1

Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,611.0408

Read SEC document
February 09, 2026 Filed Feb 10, 2026 22:05 UTC
Singhal PriyaHead of Development
SaleCommon Stock 2,660 $199.83 $531,547.80
Disclosure

SEC source: 0000875045-26-000023 · form4.xml · nonDerivative · entry 5

Singhal Priya · CIK 0001769608 · Head of Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,043.1428

Read SEC document
February 06, 2026 Filed Feb 10, 2026 22:06 UTC
Viehbacher ChristopherDirector · President and CEO
Exercise / conversionRestricted Stock Unit · Derivative 15,453 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000024 · form4.xml · derivative · entry 6

Viehbacher Christopher · CIK 0001774478 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,907

Underlying: Common Stock · 15,453 shares

Expires 2028-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025.

Read SEC document
February 06, 2026 Filed Feb 10, 2026 22:06 UTC
Viehbacher ChristopherDirector · President and CEO
Exercise / conversionRestricted Stock Unit · Derivative 9,008 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000024 · form4.xml · derivative · entry 5

Viehbacher Christopher · CIK 0001774478 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,009

Underlying: Common Stock · 9,008 shares

Expires 2027-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.

Read SEC document
February 06, 2026 Filed Feb 10, 2026 22:06 UTC
Viehbacher ChristopherDirector · President and CEO
Tax withholdingCommon Stock 6,624 $201.18 $1,332,616.32
Disclosure

SEC source: 0000875045-26-000024 · form4.xml · nonDerivative · entry 4

Viehbacher Christopher · CIK 0001774478 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,924

Read SEC document
February 06, 2026 Filed Feb 10, 2026 22:06 UTC
Viehbacher ChristopherDirector · President and CEO
Exercise / conversionCommon Stock 15,453 $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000024 · form4.xml · nonDerivative · entry 3

Viehbacher Christopher · CIK 0001774478 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,548

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 06, 2026 Filed Feb 10, 2026 22:06 UTC
Viehbacher ChristopherDirector · President and CEO
Tax withholdingCommon Stock 4,356 $201.18 $876,340.08
Disclosure

SEC source: 0000875045-26-000024 · form4.xml · nonDerivative · entry 2

Viehbacher Christopher · CIK 0001774478 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,095

Read SEC document
February 06, 2026 Filed Feb 10, 2026 22:06 UTC
Viehbacher ChristopherDirector · President and CEO
Exercise / conversionCommon Stock 9,008 $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000024 · form4.xml · nonDerivative · entry 1

Viehbacher Christopher · CIK 0001774478 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,451

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 06, 2026 Filed Feb 10, 2026 22:05 UTC
Singhal PriyaHead of Development
Exercise / conversionRestricted Stock Unit · Derivative 4,683 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000023 · form4.xml · derivative · entry 7

Singhal Priya · CIK 0001769608 · Head of Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,367

Underlying: Common Stock · 4,683 shares

Expires 2028-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025.

Read SEC document
February 06, 2026 Filed Feb 10, 2026 22:05 UTC
Singhal PriyaHead of Development
Exercise / conversionRestricted Stock Unit · Derivative 2,217 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000023 · form4.xml · derivative · entry 6

Singhal Priya · CIK 0001769608 · Head of Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,217

Underlying: Common Stock · 2,217 shares

Expires 2027-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.

Read SEC document
February 06, 2026 Filed Feb 10, 2026 22:05 UTC
Singhal PriyaHead of Development
Tax withholdingCommon Stock 1,412 $201.18 $284,066.16
Disclosure

SEC source: 0000875045-26-000023 · form4.xml · nonDerivative · entry 4

Singhal Priya · CIK 0001769608 · Head of Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,703.1428

Read SEC document
February 06, 2026 Filed Feb 10, 2026 22:05 UTC
Singhal PriyaHead of Development
Exercise / conversionCommon Stock 4,683 $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000023 · form4.xml · nonDerivative · entry 3

Singhal Priya · CIK 0001769608 · Head of Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,115.1428

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 06, 2026 Filed Feb 10, 2026 22:05 UTC
Singhal PriyaHead of Development
Tax withholdingCommon Stock 1,056 $201.18 $212,446.08
Disclosure

SEC source: 0000875045-26-000023 · form4.xml · nonDerivative · entry 2

Singhal Priya · CIK 0001769608 · Head of Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,432.1428

Read SEC document
February 06, 2026 Filed Feb 10, 2026 22:05 UTC
Singhal PriyaHead of Development
Exercise / conversionCommon Stock 2,217 $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000023 · form4.xml · nonDerivative · entry 1

Singhal Priya · CIK 0001769608 · Head of Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,488.1428

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 06, 2026 Filed Feb 10, 2026 22:02 UTC
Kramer RobinChief Financial Officer
Exercise / conversionRestricted Stock Unit · Derivative 3,511 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000021 · form4.xml · derivative · entry 9

Kramer Robin · CIK 0001609222 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,024

Underlying: Common Stock · 3,511 shares

Expires 2025-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025.

Read SEC document
February 06, 2026 Filed Feb 10, 2026 22:02 UTC
Kramer RobinChief Financial Officer
Exercise / conversionRestricted Stock Unit · Derivative 703 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000875045-26-000021 · form4.xml · derivative · entry 8

Kramer Robin · CIK 0001609222 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 704

Underlying: Common Stock · 703 shares

Expires 2027-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.